Bedrijfsoverzicht
Buda Juice, Inc. is an entity focused on the production and distribution of UltraFresh juices, lemonades, limeades, and wellness shots that adhere to a clean-label philosophy by avoiding pasteurization, preservatives, GMOs, and artificial ingredients. The company operates within the Consumer Defensive sector, specifically the Beverages - Non-Alcoholic industry, positioning it as a provider of essential consumable goods that typically exhibit lower sensitivity to economic cycles compared to cyclical sectors. As of the latest data, the organization employs 39 individuals and maintains a total market capitalization of $130.44M while generating annual revenue of $12.61M. These financial figures indicate that Buda Juice, Inc. functions as a small-cap enterprise within its specific niche, operating on a relatively modest scale compared to major beverage conglomerates but maintaining a distinct presence in the organic and cold-pressed beverage sub-market.
Financiële gezondheid
The company reported a trailing twelve-month revenue of $12.61M and a corresponding net income of $3.53M, with an EBITDA of $3.69M. The significant gap between the $12.61M revenue and the $3.53M net income reveals a cost structure where operating expenses, including cost of goods sold and administrative costs, absorb approximately 72% of top-line revenue before arriving at the bottom line. Free cash flow stands at $1.65M, which provides the company with financial flexibility to manage working capital requirements or potentially fund operational improvements without immediate reliance on external financing. The gross margin is recorded at 43.8%, suggesting a pricing power or cost advantage in sourcing raw materials for organic and cold-pressed products that is higher than the industry average. Operating margins sit at 22.8%, indicating efficient management of overhead costs relative to sales volume, while the profit margin reaches 28.0%, demonstrating a highly efficient conversion of revenue into actual profit. Regarding liquidity and leverage, the company holds $1.84M in cash against $782,000 in debt, supported by a debt-to-equity ratio of 20.92 which reflects a balance sheet that is conservative rather than leveraged. The current ratio of 5.50 further confirms robust short-term liquidity, as the company possesses more than five times the current assets necessary to cover its current liabilities. Return on Equity is calculated at 102.5% and return on assets at 49.5%, metrics that reveal exceptional management effectiveness in generating returns from the shareholders' capital and the total asset base respectively.
Waarderingsbeoordeling
The trailing twelve-month P/E ratio is 37.07, whereas the forward P/E is listed as N/A, implying that analysts do not have a specific forward earnings estimate available to project the expected earnings trajectory for the immediate future. The price-to-book ratio stands at 34.95, indicating that the market values the company at a substantial premium of over 34 times its book value, likely reflecting intangible assets such as brand equity in the wellness sector rather than physical asset value. Alternative valuation metrics include a price-to-sales ratio of 10.35 and an EV/EBITDA of 35.08, which suggest that investors are willing to pay a high multiple for revenue and earnings generation relative to the company's enterprise value. The stock has traded within a 52-week range with a high of $12.00 and a low of $6.85, providing a clear historical price context for valuation analysis. Given the 52-week high of $12.00, the current market price sits below the recent peak, offering a reference point for analyzing short-term price compression or consolidation relative to the high-water mark. The beta value is N/A, meaning that historical volatility data relative to the broader market is not available for this specific security, limiting the ability to assess systematic risk using standard beta coefficients.
Growth & Income
Revenue growth year-over-year is recorded at 4.4%, while earnings growth year-over-year is -20.0%, indicating that earnings are currently growing significantly slower than revenue, which implies a temporary pressure on margins or a one-time expense impacting profitability. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which signifies that the firm retains all earnings to reinvest into growth initiatives, inventory expansion, or operational scaling rather than distributing cash to shareholders. This retention strategy aligns with the company's stage of development and the need to fund growth without relying on debt or equity issuance. Overall, the growth and income profile for Buda Juice, Inc. is characterized by modest top-line expansion accompanied by a contraction in net income, funded entirely through retained earnings rather than dividend distributions to the investing public.